Virtual screening and fast automated docking methods.

Recent advances in high-throughput protein structure determination and in computational chemistry have refocused attention on virtual screening and fast automated docking methods. This review provides a brief introduction to the basic ideas and outlines computational tools currently used. We also provide several examples of where virtual screening has proved successful, highlighting the usefulness of the approach.

[1]  J D Hirst,et al.  Predicting ligand binding energies. , 1998, Current opinion in drug discovery & development.

[2]  P. Dean,et al.  Recent advances in structure-based rational drug design. , 2000, Current opinion in structural biology.

[3]  Hugo O. Villar,et al.  Statistical relationships among docking scores for different protein binding sites , 2000, J. Comput. Aided Mol. Des..

[4]  Hans-Joachim Böhm,et al.  The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..

[5]  Osman F. Güner,et al.  Pharmacophore perception, development, and use in drug design , 2000 .

[6]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[7]  A R Leach,et al.  Synergy between combinatorial chemistry and de novo design. , 2000, Journal of molecular graphics & modelling.

[8]  M Rarey,et al.  Detailed analysis of scoring functions for virtual screening. , 2001, Journal of medicinal chemistry.

[9]  M Karplus,et al.  HOOK: A program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site , 1994, Proteins.

[10]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[11]  D. Rognan,et al.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.

[12]  David E. Clark,et al.  MOLMAKER: De Novo Generation of 3D Databases for Use in Drug Design , 1996, J. Chem. Inf. Comput. Sci..

[13]  M. Murcko,et al.  GroupBuild: a fragment-based method for de novo drug design. , 1993, Journal of medicinal chemistry.

[14]  J S Mason,et al.  Library design and virtual screening using multiple 4-point pharmacophore fingerprints. , 1999, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[15]  Valerie J. Gillet,et al.  SPROUT: A program for structure generation , 1993, J. Comput. Aided Mol. Des..

[16]  David E. Clark,et al.  PRO_SELECT: Combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology , 1997, J. Comput. Aided Mol. Des..

[17]  P Burkhard,et al.  The discovery of steroids and other novel FKBP inhibitors using a molecular docking program. , 1999, Journal of molecular biology.

[18]  Sergio H. Rotstein,et al.  GroupBuild: a fragment-based method for de novo drug design , 1994 .

[19]  Petra Schneider,et al.  De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks , 2000, J. Comput. Aided Mol. Des..

[20]  M. Murcko,et al.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.

[21]  D K Gehlhaar,et al.  De novo design of enzyme inhibitors by Monte Carlo ligand generation. , 1995, Journal of medicinal chemistry.

[22]  Akiko Itai,et al.  Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation , 1991 .

[23]  Mark A. Murcko,et al.  GenStar: A method for de novo drug design , 1993, J. Comput. Aided Mol. Des..

[24]  Hans-Joachim Böhm,et al.  Combinatorial docking and combinatorial chemistry: Design of potent non-peptide thrombin inhibitors , 1999, J. Comput. Aided Mol. Des..

[25]  I. Kuntz,et al.  Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. , 2001, Journal of medicinal chemistry.

[26]  Regine Bohacek,et al.  Multiple Highly Diverse Structures Complementary to Enzyme Binding Sites: Results of Extensive Application of a de Novo Design Method Incorporating Combinatorial Growth , 1994 .

[27]  Michael M. Hann,et al.  RECAP — Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry. , 1998 .

[28]  Alférez Mj,et al.  Evaluation of the method , 1968, Definitions.

[29]  D. Kostrewa,et al.  Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. , 2000, Journal of medicinal chemistry.

[30]  Chris M. W. Ho,et al.  SPLICE: A program to assemble partial query solutions from three-dimensional database searches into novel ligands , 1993, J. Comput. Aided Mol. Des..

[31]  D. Joseph-McCarthy.  Computational approaches to structure-based ligand design. , 1999, Pharmacology & therapeutics.

[32]  Mark A. Murcko,et al.  Virtual screening : an overview , 1998 .

[33]  M. Mizutani,et al.  Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis. , 2001, Journal of medicinal chemistry.

[34]  D. Bailey,et al.  High-throughput chemistry and structure-based design: survival of the smartest. , 2001, Drug discovery today.

[35]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[36]  Paul A. Bartlett,et al.  CAVEAT: A program to facilitate the design of organic molecules , 1994, J. Comput. Aided Mol. Des..

[37]  M. Karplus,et al.  Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.

[38]  Ajay,et al.  Computational methods to predict binding free energy in ligand-receptor complexes. , 1995, Journal of medicinal chemistry.

[39]  Colin McMartin,et al.  QXP: Powerful, rapid computer algorithms for structure-based drug design , 1997, J. Comput. Aided Mol. Des..

[40]  Todd J. A. Ewing,et al.  DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..

[41]  Pickett,et al.  Computational methods for the prediction of 'drug-likeness' , 2000, Drug discovery today.

[42]  Chris M. W. Ho,et al.  FOUNDATION: A program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three-dimensional databases , 1993, J. Comput. Aided Mol. Des..

[43]  Kirsch,et al.  Virtual Screening for Bioactive Molecules by Evolutionary De Novo Design Special thanks to Neil R. Taylor for his help in preparation of the manuscript. , 2000, Angewandte Chemie.

[44]  Yuan-Ping Pang,et al.  Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads. , 2000, Journal of medicinal chemistry.

[45]  Ruben Abagyan,et al.  Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR , 2000, J. Comput. Aided Mol. Des..

[46]  Eugene I. Shakhnovich,et al.  SMOG : DE NOVO DESIGN METHOD BASED ON SIMPLE, FAST, AND ACCURATE FREE ENERGY ESTIMATES. 2. CASE STUDIES IN MOLECULAR DESIGN , 1997 .

[47]  Martin Stahl,et al.  Structure‐Based Library Design , 2000 .

[48]  Barry Robson,et al.  PRO_LIGAND: An approach to de novo molecular design. 1. Application to the design of organic molecules , 1995, J. Comput. Aided Mol. Des..

[49]  M Karplus,et al.  An automated method for dynamic ligand design , 1995, Proteins.

[50]  G. Schneider,et al.  Peptide design by artificial neural networks and computer-based evolutionary search. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  W. Howe,et al.  Computer design of bioactive molecules: A method for receptor‐based de novo ligand design , 1991, Proteins.

[52]  N. Cohen,et al.  The NEWLEAD Program: A New Method for the Design of Candidate Structures from Pharmacophoric Hypotheses. , 1994 .

[53]  Barry Robson,et al.  PRO_LIGAND: An approach to de novo molecular design. 4. Application to the design of peptides , 1995, J. Comput. Aided Mol. Des..

[54]  G. Schneider,et al.  Virtual Screening for Bioactive Molecules , 2000 .

[55]  M. Murcko,et al.  CONCERTS: dynamic connection of fragments as an approach to de novo ligand design. , 1996, Journal of medicinal chemistry.

[56]  I. Muegge,et al.  Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.

[57]  Wolfgang Guba,et al.  Development of a virtual screening method for identification of "frequent hitters" in compound libraries. , 2002, Journal of medicinal chemistry.

[58]  Philip M. Dean,et al.  Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design , 1997, J. Comput. Aided Mol. Des..

[59]  Diana C. Roe,et al.  BUILDER v.2: Improving the chemistry of a de novo design strategy , 1995, J. Comput. Aided Mol. Des..

[60]  J. Tainer,et al.  Screening a peptidyl database for potential ligands to proteins with side‐chain flexibility , 1998, Proteins.